Bai YX - Search Results

1

Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy.

Ding XX, Zhu QG, Zhang SM, Guan L, Li T, Zhang L, Wang SY, Ren WL, Chen XM, Zhao J, Lin S, Liu ZZ, Bai YX, He B, Zhang HQ. Ding XX, et al. Among authors: bai yx. Oncotarget. 2017 Jun 6;8(33):55715-55730. doi: 10.18632/oncotarget.18382. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903454 Free PMC article. Review.

2

p21 participates in the regulation of anaplastic thyroid cancer cell proliferation by miR-146b.

Wang S, Chen Y, Bai Y. Wang S, et al. Oncol Lett. 2016 Sep;12(3):2018-2022. doi: 10.3892/ol.2016.4874. Epub 2016 Jul 18. Oncol Lett. 2016. PMID: 27602131 Free PMC article.

3

DIRC3 and near NABP1 genetic polymorphisms are associated laryngeal squamous cell carcinoma patient survival.

Shen Z, Ren W, Bai Y, Chen Z, Li J, Li B, Jin T, Cao P, Shao Y. Shen Z, et al. Oncotarget. 2016 Nov 29;7(48):79596-79604. doi: 10.18632/oncotarget.12865. Oncotarget. 2016. PMID: 27793000 Free PMC article.

4

Association of genetic polymorphisms with laryngeal carcinoma prognosis in a Chinese population.

Quan F, Zhang F, Bai Y, Zhou L, Yang H, Li B, Jin T, Li H, Shao Y. Quan F, et al. Oncotarget. 2017 Feb 7;8(6):10255-10263. doi: 10.18632/oncotarget.14381. Oncotarget. 2017. PMID: 28052013 Free PMC article.

5

Recombinant adeno-associated virus expressing a p53-derived apoptotic peptide (37AA) inhibits HCC cells growth in vitro and in vivo.

Zhang H, Wang Y, Bai Y, Shao Y, Bai J, Ma Z, Liu Q, Wu S. Zhang H, et al. Oncotarget. 2017 Mar 7;8(10):16801-16810. doi: 10.18632/oncotarget.15160. Oncotarget. 2017. PMID: 28187431 Free PMC article.

6

MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.

Guan L, Li T, Ai N, Wang W, He B, Bai Y, Yu Z, Li M, Dong S, Zhu Q, Ding XX, Zhang S, Li M, Tang G, Xia X, Zhao J, Lin S, Yao S, Zhang L, Chen G, Liu FE, Li X, Zhang H. Guan L, et al. J Exp Clin Cancer Res. 2019 Oct 17;38(1):417. doi: 10.1186/s13046-019-1417-3. J Exp Clin Cancer Res. 2019. PMID: 31623651 Free PMC article.

7

The Genetic Polymorphisms in the MIR17HG Gene Are Associated with the Risk of Head and Neck Squamous Cell Carcinoma in the Chinese Han Population.

Xu C, Han P, Ren W, Dai H, Bai Y, Shen Z, Li B, Shao Y. Xu C, et al. Biomed Res Int. 2020 Nov 24;2020:2329196. doi: 10.1155/2020/2329196. eCollection 2020. Biomed Res Int. 2020. PMID: 33299861 Free PMC article.

8

The effect of VAV3 polymorphisms on thyroid cancer.

Ren W, Xu C, Wang S, Li H, Dai H, Yang F, Shao Y, Bai Y. Ren W, et al. Endocrine. 2022 Jan;75(1):178-184. doi: 10.1007/s12020-021-02827-6. Epub 2021 Jul 22. Endocrine. 2022. PMID: 34292486

9

Downregulation of TMEM220 promotes tumor progression in Hepatocellular Carcinoma.

Li T, Guan L, Tang G, He B, Huang L, Wang J, Li M, Bai Y, Li X, Zhang H. Li T, et al. Cancer Gene Ther. 2022 Jun;29(6):835-844. doi: 10.1038/s41417-021-00370-0. Epub 2021 Jul 28. Cancer Gene Ther. 2022. PMID: 34321624

10

Long non-coding RNA AGAP2-AS1 promotes cell proliferation and invasion through regulating miR-193a-3p/LOXL4 axis in laryngeal squamous cell carcinoma.

Ren P, Niu X, Zhao R, Liu J, Ren W, Dai H, Chen J, Yan J, Li B, Shao Y, Bai Y, Han P. Ren P, et al. Cell Cycle. 2022 Apr;21(7):697-707. doi: 10.1080/15384101.2021.2016197. Epub 2022 Feb 3. Cell Cycle. 2022. PMID: 35113007 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page